Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload
Marina Makrecka‐Kuka, Stanislava Korzh, Melita Videja, Kārlis Vilks, Helena Cirule, Janis Kuka, Maija Dambrova, Edgars Liepinsh
Topics & Concepts
EmpagliflozinMedicineEndocrinologyLipotoxicityBeta oxidationInternal medicineFatty acidLipid metabolismFatty acid metabolismHeart failureMitochondrionDiabetes mellitusType 2 diabetesPharmacologyMetabolismBiochemistryChemistryInsulin resistanceCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients